DIABECON TABLET 60'S

Diabecon Tablet is an Ayurvedic medicine used to help manage diabetes. It may help regulate blood sugar levels and reduce diabetes-related complications.

Diabecon Tablet typically contains herbs like Shilajit, Methi, Gudmar, and Jambu. Please refer to the product label for a complete list of ingredients.

The recommended dosage of Diabecon Tablet may vary based on individual needs. It is best to consult your doctor or healthcare provider for personalized advice.

Diabecon Tablet is generally well-tolerated, but some individuals may experience mild gastrointestinal discomfort. Consult your doctor if you experience any adverse effects.

Diabecon Tablet can be taken with other diabetes medications, but it's essential to consult your doctor to ensure there are no interactions and your medication is adjusted appropriately.

Store Diabecon Tablet in a cool, dry place away from direct sunlight and heat. Keep out of reach of children.

Before taking Diabecon Tablet, tell your doctor about all your medical conditions, allergies, and medications you are taking.

The safety of Diabecon Tablet during pregnancy or breastfeeding is not well-established. Consult your doctor before use.

If you miss a dose of Diabecon Tablet, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Diabecon Tablet is not a cure for Type 1 diabetes, but it may help manage blood sugar levels and reduce complications associated with the condition.

Diabecon Tablet is not known to cause weight gain. Consult your doctor if you experience any changes in weight.

The time it takes to see results with Diabecon Tablet may vary from person to person. With consistent use and a healthy lifestyle, improvements may be noticed within a few weeks.

People with kidney problems should exercise caution when using Diabecon Tablet. Consult your doctor before use.

As with any medication, there can be an overdose of Diabecon Tablet. It is important to follow the recommended dosage and avoid taking more than prescribed. Seek immediate medical attention if you suspect an overdose.

Diabecon Tablet uses a specific blend of herbs known to work synergistically to manage blood sugar levels and reduce complications associated with diabetes. Consult with your doctor to compare it against other options to ensure it is right for you.

Diabecon tablet is primarily used as an adjunctive Ayurvedic formulation in the management of type 2 diabetes mellitus. It is intended to help support better control of fasting and postprandial blood glucose when used along with prescribed antidiabetic medicines, diet, and exercise. Some practitioners also use it in people with impaired glucose tolerance or prediabetes as part of a broader lifestyle and herbal regimen. It is not a replacement for insulin or standard oral antidiabetic drugs in patients who need them.

Diabecon tablet is generally not recommended as the sole treatment for diabetes, especially in moderate to severe type 2 diabetes or in type 1 diabetes. Evidence for its use as monotherapy is limited, and relying only on herbal products may lead to poor glycaemic control and increased risk of complications. It should be used as a supportive therapy in addition to, and not instead of, conventional antidiabetic medicines prescribed by your doctor, unless a qualified clinician specifically advises otherwise in carefully selected mild cases.

Diabecon tablet contains a blend of herbal ingredients that are traditionally believed to support pancreatic beta-cell function, promote insulin secretion, and improve peripheral insulin sensitivity. Some components may slow intestinal glucose absorption and have antioxidant and lipid-lowering effects. Together, these actions can contribute to modest reductions in blood glucose and support metabolic health. However, the exact mechanisms and the contribution of each ingredient are not fully established in large, well-controlled clinical studies.

Diabecon tablet is often used alongside other antidiabetic medicines such as metformin, sulfonylureas, DPP-4 inhibitors, or insulin. However, combining therapies can increase the risk of hypoglycaemia, particularly when used with insulin or sulfonylureas. Therefore, it should only be started under medical supervision. Your doctor may advise more frequent blood glucose monitoring and may adjust the doses of your existing medicines if your glycaemic control improves after adding Diabecon.

On its own, Diabecon tablet is less likely to cause significant hypoglycaemia compared with many conventional antidiabetic drugs. However, when used together with insulin or oral hypoglycaemic agents such as sulfonylureas, the combined effect on blood glucose can lead to low blood sugar. Symptoms may include sweating, shakiness, hunger, palpitations, headache, confusion, or dizziness. If such symptoms occur, check your blood glucose if possible, take fast-acting carbohydrates as advised by your doctor, and seek medical advice regarding adjustment of your treatment.

The onset and extent of benefit from Diabecon tablet can vary between individuals. Some people may notice improvements in fasting or postprandial blood glucose within a few weeks, while more stable changes in HbA1c typically require at least 8 to 12 weeks of consistent use along with diet and exercise. Regular monitoring of blood glucose and periodic HbA1c testing are important to assess response. If there is no meaningful improvement after an adequate trial period, your doctor may reconsider the need for continuing the product.

Diabecon tablet is not a substitute for insulin and should not be used as primary therapy in type 1 diabetes mellitus. People with type 1 diabetes require lifelong insulin therapy. In selected cases, some clinicians may consider herbal adjuncts under strict supervision, but this should never delay, reduce, or replace appropriate insulin dosing. Any changes in therapy for type 1 diabetes must be guided by an endocrinologist or a physician experienced in managing this condition.

Most people tolerate Diabecon tablet reasonably well when used at recommended doses. Possible side effects, based on its herbal nature, may include mild gastrointestinal symptoms such as nausea, abdominal discomfort, diarrhoea, or constipation. Rarely, allergic reactions such as rash, itching, or swelling may occur in sensitive individuals. Because herbal formulations can vary, there is also a theoretical risk of liver or kidney effects, particularly with prolonged use or in people with pre-existing organ disease. Any unusual symptoms should be reported to a healthcare professional promptly.

You should not stop or reduce any prescribed antidiabetic medicines on your own after starting Diabecon tablet. Abrupt discontinuation of conventional therapy can lead to uncontrolled blood glucose and increase the risk of acute and chronic complications. Any adjustment in your treatment plan, including dose reduction or discontinuation of medicines, must be made only by your treating physician after reviewing your blood glucose records, HbA1c, overall health status, and response to therapy.

Diabecon tablet should be avoided or used with caution in certain groups. These include individuals with known allergy or hypersensitivity to any of its herbal ingredients, people with significant liver or kidney impairment unless a specialist approves its use, pregnant or breastfeeding women without medical advice, and children unless specifically recommended by a paediatric specialist familiar with the product. Patients taking multiple medicines that may interact with herbal products should also consult their doctor before starting Diabecon.

Diabecon tablet is primarily aimed at supporting glycaemic control. Better blood glucose control over time can indirectly help reduce the risk of diabetes-related complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease. Some herbal ingredients are traditionally believed to have antioxidant and organ-protective properties. However, Diabecon should not be considered a stand-alone treatment for established complications, and there is limited high-quality clinical evidence specifically demonstrating reversal or significant modification of complications. Standard medical management and regular screening remain essential.